Hair thinning has been noted in association with retatrutide, likely related to rapid weight loss triggering telogen effluvium, though a direct pharmacological effect cannot be excluded as alopecia is listed as an adverse reaction with some licensed GLP-1 receptor agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the management of type 2 diabetes mellitus and, more recently, obesity
However, clinical trial data to date have not identified increased rates of pancreatitis or thyroid neoplasms with Retatrutide Powder
Tesofensine is particularly useful for patients experiencing metabolic slowdown or those at high risk of regaining weight
This extended presence triggers stronger satiety signals, often manifesting as nausea or cramping
Still, if you notice unusual tingling or altered sensation, that is something to take seriously and monitor